Chemotherapy and terminal skeletal muscle differentiation in WT1‐mutant Wilms tumors

Ítems similars

• Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different WT1 Mutations
  per: Royer-Pokora, Brigitte, et al.
  Publicat: (2020)
• Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation
  per: Busch, Maike, et al.
  Publicat: (2014)
• Different CTNNB1 mutations as molecular genetic proof for the independent origin of four Wilms tumours in a patient with a novel germ line WT1 mutation
  per: Uschkereit, Constanze, et al.
  Publicat: (2007)
• Establishment of a Conditionally Immortalized Wilms Tumor Cell Line with a Homozygous WT1 Deletion within a Heterozygous 11p13 Deletion and UPD Limited to 11p15
  per: Brandt, Artur, et al.
  Publicat: (2016)
• Establishment of a Conditionally Immortalized Wilms Tumor Cell Line with a Homozygous WT1 Deletion within a Heterozygous 11p13 Deletion and UPD Limited to 11p15.
  per: Artur Brandt, et al.
  Publicat: (2016-01-01)